SK51198A3 - Method for producing n-[1(r)-[(1,2-dihydro-1- -methanesulfonylspiro[3h-indole-3,4'-piperidine-1'-yl)carbonyl]- -2-(phenylmethyloxy)ethyl]-2-amino-2-methylpropanamide - Google Patents

Method for producing n-[1(r)-[(1,2-dihydro-1- -methanesulfonylspiro[3h-indole-3,4'-piperidine-1'-yl)carbonyl]- -2-(phenylmethyloxy)ethyl]-2-amino-2-methylpropanamide Download PDF

Info

Publication number
SK51198A3
SK51198A3 SK511-98A SK51198A SK51198A3 SK 51198 A3 SK51198 A3 SK 51198A3 SK 51198 A SK51198 A SK 51198A SK 51198 A3 SK51198 A3 SK 51198A3
Authority
SK
Slovakia
Prior art keywords
compound
formula
amino
acid
protecting group
Prior art date
Application number
SK511-98A
Other languages
English (en)
Slovak (sk)
Inventor
Peter G Houghton
Ioannis Houpis
Audrey Molina
Joseph E Lynch
Ralph P Volante
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9602949.1A external-priority patent/GB9602949D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SK51198A3 publication Critical patent/SK51198A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK511-98A 1995-10-27 1996-10-23 Method for producing n-[1(r)-[(1,2-dihydro-1- -methanesulfonylspiro[3h-indole-3,4'-piperidine-1'-yl)carbonyl]- -2-(phenylmethyloxy)ethyl]-2-amino-2-methylpropanamide SK51198A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US589895P 1995-10-27 1995-10-27
GBGB9602949.1A GB9602949D0 (en) 1996-02-13 1996-02-13 Process for the preparation of a growth hormone secretagogue
PCT/US1996/016954 WO1997015573A1 (en) 1995-10-27 1996-10-23 Process for the preparation of a growth hormone secretagogue

Publications (1)

Publication Number Publication Date
SK51198A3 true SK51198A3 (en) 1998-11-04

Family

ID=26308687

Family Applications (1)

Application Number Title Priority Date Filing Date
SK511-98A SK51198A3 (en) 1995-10-27 1996-10-23 Method for producing n-[1(r)-[(1,2-dihydro-1- -methanesulfonylspiro[3h-indole-3,4'-piperidine-1'-yl)carbonyl]- -2-(phenylmethyloxy)ethyl]-2-amino-2-methylpropanamide

Country Status (14)

Country Link
EP (1) EP0863900A1 (hu)
JP (1) JPH11513984A (hu)
KR (1) KR19990067097A (hu)
AR (1) AR004124A1 (hu)
AU (1) AU7468596A (hu)
BR (1) BR9610887A (hu)
CA (1) CA2235511A1 (hu)
CZ (1) CZ128298A3 (hu)
HR (1) HRP960494A2 (hu)
HU (1) HUP9902095A3 (hu)
PL (1) PL326428A1 (hu)
SK (1) SK51198A3 (hu)
WO (1) WO1997015573A1 (hu)
YU (1) YU56596A (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601724D0 (en) * 1996-01-29 1996-03-27 Merck Sharp & Dohme Therapeutic agents
AU4993497A (en) * 1996-10-25 1998-05-22 Merck & Co., Inc. Convergent process for the preparation of a growth hormone secretagogue
US6329342B1 (en) 1997-08-19 2001-12-11 Eli Lilly And Company Treatment of congestive heart failure with growth hormone secretagogues
US6639076B1 (en) 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
US6828331B1 (en) 1999-02-19 2004-12-07 Eli Lilly And Company Growth hormone secretagogues
ES2333097T3 (es) 2000-05-31 2010-02-17 Raqualia Pharma Inc Uso de secretagogos de la hormona de crecimiento para estimular la motilidad gastrointestinal.
US7125840B2 (en) 2001-10-09 2006-10-24 Eli Lilly And Company Substituted dipeptides as growth hormone secretagogues
AU2003218337A1 (en) 2002-04-09 2003-10-27 Eli Lilly And Company Growth hormone secretagogues
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
AU2008241532A1 (en) 2007-02-09 2008-10-30 Tranzyme Pharma, Inc. Macrocyclic ghrelin receptor modulators and methods of using the same
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
US20170121385A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2168512C2 (ru) * 1992-12-11 2001-06-10 Мерк Энд Ко., Инк. Спиропиперидины, способы их получения (варианты)

Also Published As

Publication number Publication date
CA2235511A1 (en) 1997-05-01
WO1997015573A1 (en) 1997-05-01
HRP960494A2 (en) 1998-04-30
MX9803316A (es) 1998-09-30
AU7468596A (en) 1997-05-15
PL326428A1 (en) 1998-09-14
JPH11513984A (ja) 1999-11-30
HUP9902095A3 (en) 2001-05-28
AR004124A1 (es) 1998-09-30
BR9610887A (pt) 1999-07-13
KR19990067097A (ko) 1999-08-16
YU56596A (sh) 1999-09-27
CZ128298A3 (cs) 1998-07-15
EP0863900A1 (en) 1998-09-16
HUP9902095A2 (hu) 1999-10-28

Similar Documents

Publication Publication Date Title
US6255285B1 (en) Phenethylamine derivatives
SK51198A3 (en) Method for producing n-[1(r)-[(1,2-dihydro-1- -methanesulfonylspiro[3h-indole-3,4'-piperidine-1'-yl)carbonyl]- -2-(phenylmethyloxy)ethyl]-2-amino-2-methylpropanamide
US5767124A (en) Polymorphic forms of a growth hormone secretagogue
FR2575753A1 (fr) Nouveaux derives peptidiques a structure polycyclique azotee, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2000516639A (ja) 成長ホルモン分泌促進薬としてのジペプチド誘導体
CZ293423B6 (cs) Heterocyklické dipeptidové sloučeniny, jejich použití a farmaceutické kompozice na jejich bázi a meziprodukty
US5723616A (en) Process for the preparation of a growth hormone secretagogue
PL194560B1 (pl) Związki o właściwościach uwalniania hormonu wzrostu, kompozycja farmaceutyczna zawierająca te związki oraz ich zastosowanie
CN1420878A (zh) 具有释放生长激素特性的化合物
US11370755B2 (en) Compositions of trofinetide
US7250399B2 (en) Compounds having growth hormone releasing activity
US6046333A (en) Convergent process for the preparation of a growth hormone secretagogue
WO1998018815A1 (en) Convergent process for the preparation of a growth hormone secretagogue
US4018912A (en) Tripeptide derivatives with central nervous system activity and preparation thereof
DE60010711T2 (de) Amido-spiropiperidine promovieren die freisetzung von wachstumshormonen
EP0823904A1 (en) Process for the preparation of spiroindolines
US6028196A (en) Process for the preparation of a growth hormone secretagogue
SK13442000A3 (sk) Postup na prípravu tetrapeptidu
JP3204266B2 (ja) 成長ホルモン分泌促進剤の多形形態
MXPA98003316A (en) Procedure for preparing a secretagogo de hormona de crecimie
US6417397B1 (en) N-substituted alkylamino acids for use as amino-protecting groups
JPH07316193A (ja) ペプチド誘導体およびその用途
JP2002069059A (ja) ピラジノン環を含む新規なオピオイドペプチド誘導体
US20070037845A1 (en) Peptido-mimetic compounds containing rgd sequence useful as integrin inhibitors, and intermediates thereof
USRE30496E (en) Tripeptide derivatives with central nervous system activity and preparation thereof